Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pheochromocytoma × Drug Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 14 Carcinoma, Non-Small-Cell Lung 13 Neoplasms 10 Head and Neck Neoplasms 8 Carcinoma, Squamous Cell 8 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Glioblastoma 7 Colorectal Neoplasms 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Recurrence 5 Pancreatic Neoplasms 5 Melanoma 5 Leukemia 5 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Fallopian Tube Neoplasms 4 Anemia, Refractory, with Excess of Blasts 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Rectal Neoplasms 3 Lymphoma, Follicular 3 Colonic Neoplasms 3 Brain Neoplasms 3 Treatment 2 Sarcoma 2 Pleural Effusion, Malignant 2 Pharyngeal Neoplasms 2

Interventions

3-Iodobenzylguanidine 3 cabozantinib 2 tipifarnib 1 pembrolizumab 1 pazopanib 1 lutetium Lu 177 dotatate 1 lenvatinib 1 guadecitabine 1 fostamatinib 1 copper dotatate CU-64 1 atezolizumab 1 Temozolomide 1 Surgical Procedures, Operative 1 Sunitinib 1 Phenoxybenzamine 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Everolimus 1 Erlotinib Hydrochloride 1 Doxazosin 1 Capecitabine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡